胰弹性蛋白酶检测试剂盒（酶联免疫法）

The fecal pancreatic Elastase ELISA from BIOSERV Diagnostics has been registered with the FDA

For the diagnosis of a pancreatic insufficiency

In-vitro test kit for the quantitative detection of human fecal pancreatic elastase in stool in order to diagnose and quantify pancreatic insufficiency.

Advantages of determining fecal pancreatic elastase:

• Fecal pancreatic Elastase is exclusively produced in the pancreas and therefore excellently suitable to diagnose pancreatic malfunctions like pancreatic insufficiency

• Fecal pancreatic Elastase is extraordinary stable when passing through the bowels

• Pancreatic Elastase is enriched 5-6 fold in feces in comparison to the concentration in the duodenal juice

• Fecal pancreatic Elastase has a small intra-personal variation in regarding the concentration

• Direct correlation of fecal pancreatic Elastase concentration and pancreatic function

• no age-dependency of the fecal pancreatic elastase secretion from infancy (first year) on

• the fecal pancreatic elastase molecule is stable for at least 6 days at refrigeration and for at least 3 days at room temperature

• FDA-registered

The Bioserv Elastase ELISA for the detection of fecal pancreatic Elastase allows a highly sensitive and specific determination of fecal pancreatic Elastase, enabling the clinician to establish a prompt and reliable diagnosis of suspected cases of pancreatic insufficiency.